Press release
World Courier and ICS Become First End-to-End Specialty Logistics Provider for Advanced Therapies
Unified solutions improve customer experience, speed of innovation and patient outcomes
VALLEY
FORGE, Pa. – AmerisourceBergen has enhanced its logistics offering by integrating
two of its businesses, World Courier, a global logistics provider, and ICS, a
third party logistics (3PL) provider, creating the first and only specialty
logistics partner to deliver complete support from clinical trials through
commercialization. The integration offers enhanced global capabilities for
manufacturers navigating the complexities of their product’s journey end-to-end,
ultimately progressing the global growth of the advanced therapy industry and
enabling more patients to be treated with these life-changing products.
“We know the promise that highly specialized treatments, such as cell and gene therapies, bring to the market is enormous. We also recognize that to achieve the best clinical outcomes, therapy innovators must be flanked with the support of a partner with broad expertise, global reach and flawless supply chain execution,” said Sam Herbert, president of World Courier and ICS. “Integrating our expertise enhances our support for partners’ development and commercialization needs and allows us to offer a complete and personalized logistics solution that enables them to stay focused on their core mission of innovation for enhanced patient outcomes.”
Expanding on decades in the clinical trial and commercial 3PL space, World Courier and ICS will create a single partner for manufacturers, with the aim of reducing complexity and improving customer experience while offering a unified world class logistics platform with the highest quality standards.
The integrated organization will also offer a complete cryogenic supply chain. With highly complex and patient-centric structures, cell and gene therapies have challenged the traditional process of specialty products. To manage this complexity for allogeneic products, World Courier and ICS offer vapor-charged cryogenic storage with fully automated technology and temperature-controlled transport from the manufacturer location to a storage facility and then to each point of care in dry shippers, while navigating international borders and maintaining temperature requirements.
By leveraging its existing global quality standards and global footprint, World Courier can charge dry shipments across its network of more than 140 offices, enabling access to cryogenic shipping solutions close to patient and manufacturing locations and create more flexibility and faster response times for patient and hospital needs.
For more information about logistic platforms to support the clinical development and commercialization of therapies, please visit www.worldcourier.com and www.icsconnect.com.
About AmerisourceBergen
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work—and powered by our 22,000 associates—we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500, with more than $175 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. Learn more at www.amerisourcebergen.com.
About World Courier
World Courier provides unparalleled specialty logistics services to drive the commercial success of our partners around the globe. For 50 years, we’ve delivered peace of mind through world-class supply chain programs, transportation services, storage of time- and temperature-sensitive products, and innovative, cutting-edge medicines including cell and gene therapies. Through our daily work – and powered by our nearly 3,000 associates – we are united in our responsibility to create healthier futures. With a presence in 50+ countries, World Courier is driven by a commitment to excellence, and provides customized solutions with global reach to increase access to care; making us the most trusted specialty logistics company in the world. Learn more at worldcourier.com.
About ICS
ICS is a leader in innovative distribution services for pharmaceutical manufacturers and an AmerisourceBergen company. As the first pharmaceutical third-party logistics provider with ISO 9001:2015 certification, ICS customizes solutions for pharmaceutical specialty medications, branded and generic pharmaceuticals, biosimilars and innovative therapies such as cell and gene therapies. Integrated business solutions are designed to support pharmaceutical manufacturers regardless of size of the operation and across the commercialization journey. ICS aligns supply chain strategy to pharmaceutical manufacturers’ business goals, delivering tailored healthcare logistics solutions that increase supply chain efficiency, maximize return on investments and enhance patient care. More information at www.ICSConnect.com on LinkedIn or Twitter @ICSConnect.
“We know the promise that highly specialized treatments, such as cell and gene therapies, bring to the market is enormous. We also recognize that to achieve the best clinical outcomes, therapy innovators must be flanked with the support of a partner with broad expertise, global reach and flawless supply chain execution,” said Sam Herbert, president of World Courier and ICS. “Integrating our expertise enhances our support for partners’ development and commercialization needs and allows us to offer a complete and personalized logistics solution that enables them to stay focused on their core mission of innovation for enhanced patient outcomes.”
Expanding on decades in the clinical trial and commercial 3PL space, World Courier and ICS will create a single partner for manufacturers, with the aim of reducing complexity and improving customer experience while offering a unified world class logistics platform with the highest quality standards.
The integrated organization will also offer a complete cryogenic supply chain. With highly complex and patient-centric structures, cell and gene therapies have challenged the traditional process of specialty products. To manage this complexity for allogeneic products, World Courier and ICS offer vapor-charged cryogenic storage with fully automated technology and temperature-controlled transport from the manufacturer location to a storage facility and then to each point of care in dry shippers, while navigating international borders and maintaining temperature requirements.
By leveraging its existing global quality standards and global footprint, World Courier can charge dry shipments across its network of more than 140 offices, enabling access to cryogenic shipping solutions close to patient and manufacturing locations and create more flexibility and faster response times for patient and hospital needs.
For more information about logistic platforms to support the clinical development and commercialization of therapies, please visit www.worldcourier.com and www.icsconnect.com.
About AmerisourceBergen
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work—and powered by our 22,000 associates—we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500, with more than $175 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. Learn more at www.amerisourcebergen.com.
About World Courier
World Courier provides unparalleled specialty logistics services to drive the commercial success of our partners around the globe. For 50 years, we’ve delivered peace of mind through world-class supply chain programs, transportation services, storage of time- and temperature-sensitive products, and innovative, cutting-edge medicines including cell and gene therapies. Through our daily work – and powered by our nearly 3,000 associates – we are united in our responsibility to create healthier futures. With a presence in 50+ countries, World Courier is driven by a commitment to excellence, and provides customized solutions with global reach to increase access to care; making us the most trusted specialty logistics company in the world. Learn more at worldcourier.com.
About ICS
ICS is a leader in innovative distribution services for pharmaceutical manufacturers and an AmerisourceBergen company. As the first pharmaceutical third-party logistics provider with ISO 9001:2015 certification, ICS customizes solutions for pharmaceutical specialty medications, branded and generic pharmaceuticals, biosimilars and innovative therapies such as cell and gene therapies. Integrated business solutions are designed to support pharmaceutical manufacturers regardless of size of the operation and across the commercialization journey. ICS aligns supply chain strategy to pharmaceutical manufacturers’ business goals, delivering tailored healthcare logistics solutions that increase supply chain efficiency, maximize return on investments and enhance patient care. More information at www.ICSConnect.com on LinkedIn or Twitter @ICSConnect.
Related content
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.